ArticleBMC pulmonary medicine2026
CT image-based machine learning models for predicting blood eosinophil levels in acute exacerbation of chronic obstructive pulmonary disease.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAcute exacerbation of chronic obstructive pulmonary disease (AECOPD) is characterized by a significant worsening of respiratory symptoms. Blood eosinophil levels are a key predictor of glucocorticoid efficacy in AECOPD patients; however, their stability can present challenges. Predicting stable eosinophil levels from CT images is essential for optimal patient management.
methodsThis study utilized CT images from 482 AECOPD patients across two hospitals. Dataset 1 comprised 193 patients for model development, while Dataset 2 included 289 patients for external validation. A threshold of 2% eosinophil was used to differentiate between high and low eosinophil levels. A machine learning model was developed to predict eosinophil levels using CT radiomics and quantitative computed tomography (QCT) features. Radiomics features were extracted, and feature selection was performed using random forest (RF) algorithms. Segmentation of pulmonary lobes, airways, and blood vessels yielded 20 QCT features. A Gradient Boosting (GB) classifier was then trained on the fused features.
resultsThe GB classifier with radiomics features demonstrated strong performance, achieving an accuracy (ACC) of 0.734 and an area under the curve (AUC) of 0.838 on the test set of Dataset 1. In external validation, the ACC and AUC were 0.624 and 0.671, respectively. After fusing QCT features, the ACC and AUC improved to 0.786 and 0.843, respectively, with external validation results of 0.673 and 0.697.
conclusionThe CT image-based machine learning model can predict blood eosinophil levels in AECOPD patients, providing a noninvasive and stable assessment. It has potential for future clinical application following further validation and external testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.